Literature DB >> 27097951

Universality analysis of the existence of substantia nigra "swallow tail" appearance of non-Parkinson patients in 3T SWI.

P Gao1, P-Y Zhou, P-Q Wang, G-B Zhang, J-Z Liu, F Xu, F Yang, X-X Wu, G Li.   

Abstract

OBJECTIVE: To use the 3.0T susceptibility-weighted imaging (SWI) for universality analysis of the "swallow tail" appearance in the substantia nigra of non-Parkinson disease and discuss its lack of the value of imaging diagnosis of Parkinson disease (PD). PATIENTS AND METHODS: Take 3.0TMR SWI in 60 PD patients (Group PD) and non-PD volunteers (Group N-PD), on the map of range analyze morphology and number of "swallow tail" appearance in substantia nigra of N-PD group volunteers, and compare the performance image of the corresponding region of the patients in the PD group.
RESULTS: After, 15 patients with lesions in the brain stem and significant motion artifacts were excluded. Forty-nine cases of group N-PD (96.08%) had typical "swallow tail" appearance in the bilateral or unilateral substantia nigra compacta posterolateral. All 54 patients with group PD (100%) lacked the "drop" rear elliptical high signal.
CONCLUSIONS: On the 3.0T SWI range map, the "swallow tail" appearance is ubiquitous in the substantia nigra of patients with non-PD. The deficiency of the signs has high sensitivity and specificity for PD diagnosis.

Entities:  

Mesh:

Year:  2016        PMID: 27097951

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  9 in total

Review 1.  Nigrosome 1 imaging: technical considerations and clinical applications.

Authors:  Eung Yeop Kim; Young Hee Sung; Jongho Lee
Journal:  Br J Radiol       Date:  2019-06-05       Impact factor: 3.039

2.  Using 'swallow-tail' sign and putaminal hypointensity as biomarkers to distinguish multiple system atrophy from idiopathic Parkinson's disease: A susceptibility-weighted imaging study.

Authors:  Na Wang; HuaGuang Yang; ChengBo Li; GuoGuang Fan; XiaoGuang Luo
Journal:  Eur Radiol       Date:  2017-01-19       Impact factor: 5.315

3.  Iron-sensitive magnetic resonance imaging in Parkinson's disease: a systematic review and meta-analysis.

Authors:  Se Jin Cho; Yun Jung Bae; Jong-Min Kim; Hyun Jin Kim; Sung Hyun Baik; Leonard Sunwoo; Byung Se Choi; Cheolkyu Jung; Jae Hyoung Kim
Journal:  J Neurol       Date:  2021-04-29       Impact factor: 4.849

4.  Differential involvement of nigral subregions in idiopathic parkinson's disease.

Authors:  Young Hee Sung; Jongho Lee; Yoonho Nam; Hyeong-Geol Shin; Young Noh; Dong Hoon Shin; Eung Yeop Kim
Journal:  Hum Brain Mapp       Date:  2017-10-24       Impact factor: 5.038

5.  The Swallow Tail Sign of Substantia Nigra: A Case-Control Study to Establish Its Role in Diagnosis of Parkinson Disease on 3T MRI.

Authors:  Ruchi Gupta; Gunjan Kumar; Subhash Kumar; Bhaskar Thakur; Richa Tiwari; Amit Kumar Verma
Journal:  J Neurosci Rural Pract       Date:  2022-02-09

6.  Fast 3 T nigral hyperintensity magnetic resonance imaging in Parkinson's disease.

Authors:  Gabriella Hernadi; David Pinter; Szilvia Anett Nagy; Gergely Orsi; Samuel Komoly; Jozsef Janszky; Norbert Kovacs; Gabor Perlaki
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 7.  [MRI Findings in Parkinson's Disease: Radiologic Assessment of Nigrostriatal Degeneration].

Authors:  Yun Jung Bae; Jong-Min Kim; Byung Se Choi; Yoo Sung Song; Yoonho Nam; Se Jin Cho; Jae Hyoung Kim; Sang Eun Kim
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2022-05-25

Review 8.  Diagnostic biomarkers for Parkinson's disease at a glance: where are we?

Authors:  Ilaria Cova; Alberto Priori
Journal:  J Neural Transm (Vienna)       Date:  2018-08-25       Impact factor: 3.575

9.  Protocol of a single group prospective observational study on the diagnostic value of 3T susceptibility weighted MRI of nigrosome-1 in patients with parkinsonian symptoms: the N3iPD study (nigrosomal iron imaging in Parkinson's disease).

Authors:  Stefan T Schwarz; Yue Xing; Saadnah Naidu; Jim Birchall; Rob Skelly; Alan Perkins; Jonathan Evans; Gill Sare; Antonio Martin-Bastida; Nin Bajaj; Penny Gowland; Paola Piccini; Dorothee P Auer
Journal:  BMJ Open       Date:  2017-12-14       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.